MURAL ONCOLOGY PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.245 USD | +5.70% |
|
-0.31% | -45.27% |
| 04-04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
| 01-08 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MURAL ONCOLOGY PLC | Bio Therapeutic Drugs | +5.54% | -0.31% | -45.27% | - | - | 51.96M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MURA Stock
- Charts Mural Oncology plc
- Comparison Chart
